Eventide Asset Management’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,779
Closed -$4.58M 127
2019
Q2
$4.58M Sell
2,779
-19,967
-88% -$34.5M 0.14% 87
2019
Q1
$46.4M Buy
22,746
+1,315
+6% +$2.32M 1.6% 16
2018
Q4
$27.5M Hold
21,431
1.22% 30
2018
Q3
$40.5M Hold
21,431
1.49% 21
2018
Q2
$43.6M Hold
21,431
1.81% 10
2018
Q1
$47.4M Hold
21,431
2.22% 7
2017
Q4
$49.4M Sell
21,431
-10,375
-33% -$21.1M 2.58% 5
2017
Q3
$56.6M Sell
31,806
-12,175
-28% -$17M 3.21% 2
2017
Q2
$59.8M Hold
43,981
3.73% 1
2017
Q1
$51.8M Sell
43,981
-1,388
-3% -$1.42M 3.43% 3
2016
Q4
$36.3M Buy
45,369
+3,720
+9% +$2.95M 2.36% 8
2016
Q3
$36.6M Hold
41,649
2.23% 13
2016
Q2
$23.4M Hold
41,649
1.43% 25
2016
Q1
$22.9M Hold
41,649
1.28% 31
2015
Q4
$34.6M Buy
41,649
+9,256
+29% +$9.25M 1.73% 18
2015
Q3
$35.9M Buy
32,393
+1,297
+4% +$2.36M 2.09% 14
2015
Q2
$67.8M Hold
31,096
3.67% 2
2015
Q1
$48.6M Buy
31,096
+988
+3% +$1.3M 3.66% 1
2014
Q4
$35.8M Sell
30,108
-440
-1% -$294K 3.9% 1
2014
Q3
$14.2M Buy
30,548
+24,611
+415% +$11.4M 1.98% 13
2014
Q2
$2.97M Buy
5,937
+919
+18% +$295K 0.4% 65
2014
Q1
$1.48M Buy
5,018
+3,034
+153% +$919K 0.23% 83
2013
Q4
$539K Buy
+1,984
New +$554K 0.17% 79

Other funds holding BLUE

Eventide Asset Management's BLUE Position: Q3 2019 in Review

Eventide Asset Management sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 2,779 shares — an estimated $4.58M sold.

Eventide Asset Management first reported a position in BLUE in Q4 2013 and held it in 23 quarters. The position peaked at $67.8M in Q2 2015. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

  • Eventide Asset Management reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
  • Eventide Asset Management sold 2,779 bluebird bio shares in Q3 2019, an estimated $4.58M.
  • Eventide Asset Management first reported a position in bluebird bio in Q4 2013 and held it in 23 quarters.
  • Eventide Asset Management's bluebird bio position peaked at $67.8M in Q2 2015.
  • 241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Eventide Asset Management's 13F filing for Q3 2019, filed 21 Nov 2019.